Omalizumab for successful chemotherapy desensitisation: What we know so far.
Roxana Silvia BumbaceaSelda AliSabina Loredana CorceaLuiza SpiruCornelia NitipirVictor StrambuDragos BumbăceaPublished in: Clinical and translational allergy (2021)
We found a great heterogeneity between the doses and the interval between omalizumab injections and chemotherapy - rapid drug desensitisation, but most of the studies showed promising results. As a corollary, we propose a dose regimen of omalizumab administered before the first desensitisation protocol. Then, omalizumab should be administered one day before every chemotherapy regimen. Omalizumab might be used as an adjuvant therapy and might be a solution for a hopeless situation.